Phosphorylation of P68 RNA Helicase by P38 MAP kinase contributes to colon cancer cells apoptosis induced by oxaliplatin

被引:24
作者
Dey, Heena [1 ]
Liu, Zhi-Ren [1 ]
机构
[1] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA
来源
BMC CELL BIOLOGY | 2012年 / 13卷
关键词
P68 RNA helicase; Oxaliplatin; Phosphorylation; p38 MAP kinase; DEAD-box; Apoptosis; ACTIVATED PROTEIN-KINASE; OVARIAN-CARCINOMA; HIV-1; ENVELOPE; PATHWAY; INDUCTION; GAMMA-H2AX; TRANSITION; MECHANISMS;
D O I
10.1186/1471-2121-13-27
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: We previously demonstrated that p68 phosphorylation at threonine residues correlates with cancer cell apoptosis under the treatments of TNF-alpha and TRAIL (Yang, L. Mol Cancer Res Vol 3, pp 355-63 2005). Results: In this report, we characterized the role of p68 phosphorylation in apoptosis induction under the treatment of oxaliplatin in the colon cancer cells. Our data suggest that oxaliplatin treatment activates p38 MAP kinase, which subsequently phosphorylates p68 at T564 and/or T446. The phosphorylation of p68, at least partially, mediates the effects of the drug on apoptosis induction, as mutations at these two sites greatly reduce the cancer cell death. Conclusion: Our studies reveal an important molecular mechanism that mediates the effects of anti-cancer drug, providing a potential strategy for improving cancer treatment.
引用
收藏
页数:8
相关论文
共 40 条
  • [1] Transcription Inhibition by Platinum-DNA Cross-Links in Live Mammalian Cells
    Ang, Wee Han
    Myint, MyatNoeZin
    Lippard, Stephen J.
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2010, 132 (21) : 7429 - 7435
  • [2] The DEAD box protein p68: a novel transcriptional coactivator of the p53 tumour suppressor
    Bates, GJ
    Nicol, SM
    Wilson, BJ
    Jacobs, AMF
    Bourdon, JC
    Wardrop, J
    Gregory, DJ
    Lane, DP
    Perkins, ND
    Fuller-Pace, FV
    [J]. EMBO JOURNAL, 2005, 24 (03) : 543 - 553
  • [3] Overexpression and poly-ubiquitylation of the DEAD-box RNA helicase p68 in colorectal tumours
    Causevic, M
    Hislop, RG
    Kernohan, NM
    Carey, FA
    Kay, RA
    Steele, RJC
    Fuller-Pace, FV
    [J]. ONCOGENE, 2001, 20 (53) : 7734 - 7743
  • [4] Regulation of gamma-H2AX and securin contribute to apoptosis by oxaliplatin via a p38 mitogen-activated protein kinase-dependent pathway in human colorectal cancer cells
    Chiu, Shu-Jun
    Chao, Jui-I
    Lee, Yi-Jang
    Hsu, Tzu-Sheng
    [J]. TOXICOLOGY LETTERS, 2008, 179 (02) : 63 - 70
  • [5] Oxaliplatin-induced gamma-H2AX activation via both p53-dependent and -independent pathways but is not associated with cell cycle arrest in human colorectal cancer cells
    Chiu, Shu-Jun
    Lee, Yi-Jang
    Hsu, Tzu-Sheng
    Chen, Wen-Shu
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 2009, 182 (2-3) : 173 - 182
  • [6] CELLULAR PROTEINS REACTIVE WITH MONOCLONAL-ANTIBODIES DIRECTED AGAINST SIMIAN VIRUS-40 T-ANTIGEN
    CRAWFORD, L
    LEPPARD, K
    LANE, D
    HARLOW, E
    [J]. JOURNAL OF VIROLOGY, 1982, 42 (02) : 612 - 620
  • [7] Bcl-2 phosphorylation by p38 MAPK - Identification of target sites and biologic consequences
    De Chiara, Giovanna
    Marcocci, Maria Elena
    Torcia, Maria
    Lucibello, Maria
    Rosini, Paolo
    Bonini, Paolo
    Higashimoto, Yukiro
    Damonte, Gianluca
    Armirotti, Andrea
    Amodei, Sarah
    Palamara, Anna Teresa
    Russo, Tommaso
    Garaci, Enrico
    Cozzolino, Federico
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (30) : 21353 - 21361
  • [8] Involvement of p38 in apoptosis-associated membrane blebbing and nuclear condensation
    Deschesnes, RG
    Huot, J
    Valerie, K
    Landry, J
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (06) : 1569 - 1582
  • [9] Active mutants of the human p38α mitogen-activated protein kinase
    Diskin, R
    Askari, N
    Capone, R
    Engelberg, D
    Livnah, O
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (45) : 47040 - 47049
  • [10] Phase I-II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma
    Faivre, S
    Le Chevalier, T
    Monnerat, C
    Lokiec, R
    Novello, S
    Taieb, J
    Pautier, P
    Lhommé, C
    Ruffié, P
    Kayitalire, L
    Armand, JP
    Raymond, E
    [J]. ANNALS OF ONCOLOGY, 2002, 13 (09) : 1479 - 1489